共 98 条
[1]
Kumar S(2016)International myeloma working group consensus criteria for response and minimal residual disease assessment in multiple myeloma Lancet Oncol 17 e328-ee46
[2]
Paiva B(2019)International myeloma working group consensus recommendations on imaging in monoclonal plasma cell disorders Lancet Oncol 20 e302-ee12
[3]
Anderson KC(2009)International myeloma working group consensus statement and guidelines regarding the current role of imaging techniques in the diagnosis and monitoring of multiple myeloma Leukemia. 23 1545-1556
[4]
Hillengass J(2014)International myeloma working group updated criteria for the diagnosis of multiple myeloma Lancet Oncol 15 e538-ee48
[5]
Usmani S(2015)Role of magnetic resonance imaging in the management of patients with multiple myeloma: a consensus statement J Clin Oncol 33 657-664
[6]
Rajkumar SV(2016)The Role of Imaging in the Treatment of Patients With Multiple Myeloma in 2016 American Society of Clinical Oncology Educational Book 36 e407-e417
[7]
Dimopoulos M(2010)Current concepts in the evaluation of multiple myeloma with MR imaging and FDG PET/CT Radiographics. 30 127-142
[8]
Terpos E(2019)Whole-body magnetic resonance imaging (WB-MRI) in oncology: recommendations and key uses Radiol Med 124 218-233
[9]
Comenzo RL(2019)Imaging in multiple myeloma: how? When? Blood. 133 644-651
[10]
Rajkumar SV(2009)Comparison of whole-body MR imaging and conventional X-ray examination in patients with multiple myeloma and implications for therapy Ann Hematol 88 457-464